Successfully removed.
Sorry, an error occurred.
|
ItalianGBMGroup uploaded a new video
(4 hours ago)
Researchers at the University of Minnesota say there's positive news for 'Batman'—a 10-year-old German shepherd battling a rare tumor.
The school us...
more
Researchers at the University of Minnesota say there's positive news for 'Batman'—a 10-year-old German shepherd battling a rare tumor.
The school used an experimental combination of gene therapy and a vaccine to an aggressive brain tumor from Batman in 2008.
Wednesday marked his one-year check up and doctors say he's still cancer free.
"The life expectancy for this dog was probably less than two months if he had gone untreated," explained Professor John Ohlfest.
Researchers say the study could have far-reaching implications in treating brain cancer in humans.
less
|
|
| |
|
|
ItalianGBMGroup uploaded a new video
(3 days ago)
|
|
| |
|
|
ItalianGBMGroup uploaded a new video
(3 days ago)
magine this: Youre 31 and in the prime of your life. You have a family with two little girls, and the job you always dreamed of. One day, out of th...
more
magine this: Youre 31 and in the prime of your life. You have a family with two little girls, and the job you always dreamed of. One day, out of the blue, you have a seizure. The doctor sends you in for an MRI. It turns out that seizure was a symptom of something much more serious—you have brain cancer. And now, youre in the fight of your life. To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/swe...
Source BlipTv - 22 OCtober 2009
less
|
|
| |
|
|
ItalianGBMGroup uploaded a new video
(3 days ago)
The drug Avastin may improve survival rates for glioblastomas, an aggressive type of brain tumor (September 2009)
|
|
| |
|
|
ItalianGBMGroup uploaded a new video
(3 days ago)
In phase two trials, patients who got the vaccine were free of cancer for about 16 and a half months and survived nearly three years. Those who did...
more
In phase two trials, patients who got the vaccine were free of cancer for about 16 and a half months and survived nearly three years. Those who didn't get the shot saw their cancer progress six months later. They survived a little over a year. (:14)
"We've been doing this for many years. It helps to stave off disease, but is not a cure. Now, we have a treatment that potentially can increase the number of long-term survivors," Schwartz said.
"I don't think I'm back to where I was before the surgery, but I'm getting closer," Rauch said.
So far, Rauch's feeling good, and grateful for every day his cancer stays away.
Patients in the trial receive monthly injections for as long as the tumor has not returned. To be eligible for the vaccine trial, patients must be over 18, have a newly diagnosed brain tumor and recently had surgery to remove it.
For More Information, Please Contact:
Andrew Klein
Public Affairs
Newyork-Presbyterian Hospital/Weill Cornell Medical Center
(212) 821-0560
Posted: Nov 06, 2009 10:16 PM Source NewsChannel5
less
|
|
